Literature DB >> 6084063

Occlusive retinal vascular disease in systemic lupus erythematosus.

S Hall, H Buettner, H S Luthra.   

Abstract

Ocular involvement in patients with systemic lupus erythematosus (SLE) is most commonly noted in the form of retinal hemorrhage, exudates and cotton wool spots resulting from occlusion of small retinal blood vessels. Less frequently, SLE is associated with extensive obliteration of larger retinal vessels, as demonstrated in the 2 cases reported here. In both cases large parts of the retina lost their function due to extensive occlusions of retinal arteries and veins. Marked retinal neovascularizations developed in one of the 2 cases. Awareness and early detection of retinal vascular occlusive disease and its complications are important in averting serious visual loss in SLE.

Entities:  

Mesh:

Year:  1984        PMID: 6084063

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

1.  Occlusive ocular vascular disease and antiphospholipid antibodies.

Authors:  C Tolosa-Vilella; J Ordi-Ros; R Jordana-Comajuncosa; A Selva-O'Callaghan; M Vilardell-Tarres
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

2.  Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome.

Authors:  P A Ostuni; P Lazzarin; V Pengo; A Ruffatti; F Schiavon; P Gambari
Journal:  Ann Rheum Dis       Date:  1990-03       Impact factor: 19.103

3.  Anterior segment ischaemia following laser photocoagulation in a patient with systemic lupus erythematosus.

Authors:  B F Jost; R J Olk; A Patz; S L Fine; R P Murphy
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638

Review 4.  Anticardiolipin antibodies--clinical associations.

Authors:  R A Asherson; E N Harris
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

5.  Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.

Authors:  R A Asherson; P Merry; J F Acheson; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

6.  Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodies.

Authors:  M H Arnold; L Schrieber
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

7.  Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities.

Authors:  A G Bird; R Lendrum; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

8.  Ocular manifestations of systemic lupus erythematosus: a review of the literature.

Authors:  Neal V Palejwala; Harpreet S Walia; Steven Yeh
Journal:  Autoimmune Dis       Date:  2012-07-02

9.  Systemic lupus erythematosus presenting earlier as retinal vaso-occlusion.

Authors:  Y H Song; C G Kim; S D Kim; Y Y Kim; J Y Choe
Journal:  Korean J Intern Med       Date:  2001-09       Impact factor: 2.884

10.  An unusual presentation of lupus retinopathy.

Authors:  Dinesh K Sahu
Journal:  Indian J Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.